Related Experiment Videos
Inhaled nitric oxide for primary pulmonary hypertension in pregnancy
G K Lam1, R E Stafford, J Thorp
1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA. garrett_lam@med.unc.edu
Obstetrics and Gynecology
|November 13, 2001
Summary
This study shows inhaled nitric oxide therapy can successfully treat severe primary pulmonary hypertension in pregnancy, leading to a healthy infant and maternal survival.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Pulmonary Medicine
Background:
- Primary pulmonary hypertension (PPH) poses significant risks during pregnancy, with historical maternal mortality rates of 35-50%.
- Traditional treatments for pregnant patients with PPH include diuretics, digoxin, and calcium-channel blockers.
Observation:
- A case report details the management of a primigravida diagnosed with severe primary pulmonary hypertension.
- The patient underwent elective intubation prior to labor, received inhaled nitric oxide therapy, and had an assisted vaginal delivery under epidural anesthesia.
Findings:
- The intervention resulted in the successful delivery of a viable infant.
- The mother survived the peripartum period, indicating a positive treatment outcome.
Implications:
- Inhaled nitric oxide therapy presents a viable and effective treatment option for severe primary pulmonary hypertension in pregnant individuals.
- This approach may improve maternal and fetal outcomes in high-risk pregnancies complicated by PPH.